SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Mixed oncology-trial results are driving attention: traders cite BioNTechs BNT113 setback and modest breast-cancer benefit, while bulls point to other promising pipeline readouts and upcoming updates. Debate also reflects concern over the leadership transition and the time needed to turn the pipeline into commercial products.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios quarterly results beat expectations and lifted its full-year outlook, but a softer next-quarter organic growth forecast signaled deceleration and drove a sharp selloff. Traders are debating whether slowing messaging growth and weaker customer expansion outweigh the strong results, while some see the pullback as a potential bounce opportunity.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as traders discuss a shift from volatile technology and growth stocks toward dividend-paying value and defensive holdings amid market uncertainty. Many point to its recent strength and keep accumulating, while others question its yield and warn that rising Treasury yields or a return to tech could weigh on the fund.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Traders are focused on whether Q3 results will show that oral Wegovy demand and international expansion can offset concerns about Eli Lillys competitive lead in GLP-1 drugs. The community is divided: some see the pill rollout and low valuation as recovery potential, while others remain cautious about Novos execution, management and pipeline; the Hengrui licensing deal also drew debate as a longer-term pipeline move.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a fresh 52-week high has put TGTX in focus, with traders pointing to BRIUMVIs commercial growth and anticipation of earnings and upcoming subcutaneous data. Buyout and short-squeeze theories are circulating, but remain speculation; others see the rally as momentum ahead of those catalysts.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report, with record sales and revenue growth but an EPS miss and weaker margins, sparked a sharp rally and renewed short-squeeze speculation; traders are also citing the SECs decision to close its investigation without recommending enforcement. The move has drawn competing views, with bulls focused on growth and squeeze potential while bears question profitability, guidance and valuation.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

A sharp selloff and persistent volatility dominate discussion, with traders pointing to broader weakness in miners and uncertainty over Sangdongs production ramp and near-term cash flows. Some remain bullish on tungsten-market fundamentals and the mines first shipment, while others say the investor-day discussion offered little new detail and are concerned about execution.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings, supported by growth in Dupixent and Eylea HD, sparked a sharp share-price surge and a new 52-week high. Traders are broadly bullish on the breakout, while debating whether the move can hold or will retrace.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is in talks to access at least 80,000 U.S. cell sites, including Crown Castles towers, have focused attention on the prospect of a major new leasing customer. Traders see potential tower revenue upside, while skeptics note that no agreement is signed and question whether SpaceXs wireless plans will translate into meaningful demand.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A steep selloff in Aehr shares is driving discussion as traders debate whether broader AI and semiconductor weakness, valuation concerns and bearish options flow point to more downside or an oversold setup ahead of earnings. Bulls are watching guidance, backlog and potential AI test-system orders, while skeptics question execution and the companys ability to justify its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains

CL's Q3 earnings and sales beat estimates, fueled by organic growth, pricing gains and productivity efforts, prompting a higher 2026 profitability outlook.

Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026

Warby Parker Inc. (NYSE: WRBY) (the Company), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2026, will be released before market open on November 5, 2026. In addition, the Company will discuss its...

Warby Parker (WRBY) Surges 12.5%: Is This an Indication of Further Gains?

Warby Parker (WRBY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

These Stocks are Refusing to Cool Off

The closing bell is shaping up to be anything but quiet for these names that stand out as the session heads toward the finish. Greenland Energy Company (NASDAQ:GLND), NeOnc Technologies Holdings (NASDAQ:NTHI), GRAIL (NASDAQ:GRAL), Warby Parker (NYSE:WRBY), Montauk Renewables (NASDAQ:MNTK), Ginkgo Bioworks Holdings (NYSE:DNA), and CareDx (NASDAQ:CDNA).

Big Tech's Next AI Battleground Is Your Face, Loop Capital Says

Big Tech's Next AI Battleground Is Your Face, Loop Capital Says

 Smartglasses are set to be the "next major computing platform," according to Loop Capital analysts, as Meta currently leads the space, with Google, Samsung, Apple, and SNAP preparing their own AI-powered eyewear.

Loop...

Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference

Warby Parker Inc. (NYSE: WRBY) (the Company), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 33rd Annual Global Retailing Conference on Tuesday, September 15, 2026, at 11:30 a.m. Eastern Time. The presentation...

Warby Parker Co-CEO Gilboa Sells 11,504 Shares for $278,000

Key PointsThe disposal of 11,504 shares was completed at $24.19 per share for a total transaction value of ~$278,000...

Warby Parker (WRBY) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Warby Parker Q2 Earnings Call Highlights

Warby Parker Q2 Earnings Call Highlights...

Here's What Key Metrics Tell Us About Warby Parker (WRBY) Q2 Earnings

The headline numbers for Warby Parker (WRBY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on July 6, 2010 and is headquartered in New York, NY.

Warby Parker Inc - Ordinary Shares - Class A

WRBY Stock Slips: Wall Street, Retail Traders Not Impressed Enough With Google, Samsung Smart Glass Tie-Up

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Glasses will let consumers interact with Google Gemini through voice commands.</li><li>Users will be able to ask for directions, play music, take voice calls, and listen to notification summaries.</li><li>Pricing and detailed specifications are yet to be released.</li></ul>Warby Parker (<a href="https://stocktwits.com/symbol/WRBY">WRBY</a>) share price dropped 9% on Tuesday, but recovered after-hours to trade up 0.6% after the company announced a collaboration with Google and Samsung to create smart glasses, rivaling Meta and Ray-Ban.&nbsp;The lifestyle brand unveiled eyewear designed for all-day wear that integrates technology from Google and Samsung. The debut style combines Warby Parker’s design approach with Google’s AI capabilities and Samsung’s mobile technology."Glasses are the most personal technology we use, and are the very first thing people notice about you," said Dave Gilboa, Co-Founder and Co-CEO of Warby Parker. "As we integrate advanced technology into our products, we’re staying true to the principles that define great eyewear: beautiful design, precision optics, and exceptional comfort in frames built for all-day, everyday wear."The smart glass capabilities include the ability to request directions, stream music, handle voice calls, and hear summaries of incoming notifications. Users can also manage their schedule by adding calendar appointments and utilize Gemini for live translation services. Integrated camera technology allows the device to provide information about objects in the user's field of vision. Additionally, the glasses support photo and video capture via physical buttons or voice control, featuring an LED indicator to notify others when recording is in progress.“We have to raise the bar and design for privacy from the ground up,” Shahram Izadi, vice president and general manager of Android XR at Google, said in an interview with Bloomberg ahead of the design reveal.Google and Samsung plan to share more specifics around privacy safeguards over the coming months. Pricing and a specific release date for the glasses haven’t yet been revealed.<h2 class="st-heading-2">WRBY Analyst View&nbsp;</h2>Stifel kept a ‘Hold’ rating on Warby Parker after the company announced its first intelligent eyewear frame and confirmed a fall 2026 launch. "While firmer details around launch timing this fall are encouraging, we view the release as a non-event," the analyst told investors in a research note.&nbsp;BTIG analyst Janine Stichter maintained a ‘Buy’ rating on Warby Parker. Stichter believes investors may be disappointed that details like concrete timing, hardware specs, including battery life and weight, and pricing were not released.&nbsp;In addition, investors "are eagerly waiting for the full 'display' model, while only the audio version is set for '26,” Stichter added.&nbsp;<h2 class="st-heading-2">WRBY Retail View&nbsp;</h2>One user thought the glasses looked “ugly” and was expecting the collaboration with Apple instead of Google.&nbsp;<stembedurl>https://stocktwits.com/oghowie/message/653841842</stembedurl>Another user felt that partnering with Google was bad for the&nbsp;firm’s bottom line.<stembedurl>https://stocktwits.com/CrispDry/message/653844613</stembedurl>The stock has gained about 45% over the past 12 months.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/s-and-p-500-nasdaq-and-dow-end-lower-as-soaring-treasury-yields-reflect-inflation-concerns-googl-csco-hd-cost-wmt-in-focus/cZXHcLBReNo">S&amp;P 500, Nasdaq and Dow End Lower As Soaring Treasury Yields Reflect Inflation Concerns — GOOGL, CSCO, HD, COST, WMT In Focus</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Warby Parker signage is seen at a store on May 22, 2024 in Downtown Brooklyn in New York City. (Photo by Michael M. Santiago/Getty Images)

Warby Parker (WRBY) share price dropped 9% on Tuesday, but recovered after-hours to trade up 0.6% after the company announced a collaboration with Google and Samsung to create smart glasses, rivaling Meta and Ray-Ban.&nbsp;

Samsung Electronics Co. and Alphabet Inc.’s Google unveiled the designs of smart glasses co-developed with eyewear partners Warby Parker and Gentle Monster. 

Alphabet Inc Class A

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$24.61
Prev Close	$24.59
Open	$24.96
Dividend Yield	0.00%
50-Day Moving Average	$25.14
Beta	1.81
Avg. Volume	3.41M
PE Ratio	405.44

52-Week High	$31.00
52-Week Low	$14.96
Market Capitalization	$3.04B
EPS (Annual)	$0.0131
Price to Book	7.75
Revenue Per Employee	$216,031.96

Feed

News

Sentiment

Earnings

Fundamentals

Info

WRBY Fundamentals